Efficacy and Safety, Long-Term Study of NPC-01 to Treat Dysmenorrhea Associated With Endometriosis

Last updated: June 3, 2025
Sponsor: Nobelpharma
Overall Status: Completed

Phase

3

Condition

Endometriosis

Severe Premenstrual Symptom

Female Hormonal Deficiencies/abnormalities

Treatment

NPC-01

Clinical Study ID

NCT00902746
NPC-01-1
  • Ages > 18
  • Female

Study Summary

The purpose of this long-term study is to determine whether NPC-01 is effective in the treatment of dysmenorrhea associated with endometriosis.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Dysmenorrhea associated with endometriosis

Exclusion

Exclusion Criteria:

  • Severe hepatopathy

  • Pregnant woman

Study Design

Total Participants: 149
Treatment Group(s): 1
Primary Treatment: NPC-01
Phase: 3
Study Start date:
May 01, 2009
Estimated Completion Date:
February 29, 2012